LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 39

Search options

  1. Article ; Online: Development and Evaluation of Molecular Pen-Side Assays without Prior RNA Extraction for Peste des Petits Ruminants (PPR) and Foot and Mouth Disease (FMD).

    Edge, David / Mahapatra, Mana / Strachan, Shona / Turton, James / Waters, Ryan / Benfield, Camilla / Nazareth, Nathan / Njeumi, Felix / Nazareth, Nelson / Parida, Satya

    Viruses

    2022  Volume 14, Issue 4

    Abstract: Animal diseases such as peste des petits ruminants (PPR) and foot and mouth disease (FMD) cause significant economic losses in endemic countries and fast, accurate in-field diagnostics would assist with surveillance and outbreak control. The detection of ...

    Abstract Animal diseases such as peste des petits ruminants (PPR) and foot and mouth disease (FMD) cause significant economic losses in endemic countries and fast, accurate in-field diagnostics would assist with surveillance and outbreak control. The detection of these pathogens is usually performed at reference laboratories, tested using assays that are recommended by The World Organisation for Animal Health (OIE), leading to delays in pathogen detection. This study seeks to demonstrate a proof-of-concept approach for a molecular diagnostic assay that is compatible with material direct from nasal swab sampling, without the need for a prior nucleic acid extraction step, that could potentially be applied at pen-side for both PPR and FMD. The use of such a rapid, low-cost assay without the need for a cold chain could permit testing capacity to be established in remote, resource limited areas and support the surveillance activities necessary to meet the goal of eradication of PPR by 2030. Two individual assays were developed that detect > 99% of PPR and FMD sequences available in GenBank, demonstrating pan-serotype FMD and pan-lineage PPR assays. The ability for the BioGene XF reagent that was used in this study to lyse FMD and PPR viruses and amplify their nucleic acids in the presence of unprocessed nasal swab eluate was evaluated. The reagent was shown to be capable of detecting the viral RNA present in nasal swabs collected from naïve and infected target animals. A study was performed comparing the relative specificity and sensitivity of the new assays to the reference assays. The study used nasal swabs collected from animals before and after infection (12 cattle infected with FMDV and 5 goats infected with PPRV) and both PPR and FMD viral RNA were successfully detected two to four days post-infection in all animals using either the XF or reference assay reagents. These data suggest that the assays are at least as sensitive as the reference assays and support the need for further studies in a field setting.
    MeSH term(s) Animals ; Cattle ; Foot-and-Mouth Disease/diagnosis ; Goat Diseases ; Goats ; Peste-des-Petits-Ruminants ; Peste-des-petits-ruminants virus/genetics ; RNA, Viral/genetics
    Chemical Substances RNA, Viral
    Language English
    Publishing date 2022-04-17
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14040835
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Usability and acceptability of a cognitive training intervention (SMART) for people with multiple sclerosis (MS): A prefeasibility formative evaluation.

    Frost, Alexandra C / Golijani-Moghaddam, Nima / Burge, Rupert / Dawson, David L / Evangelou, Nikos / Roche, Bryan / Turton, James / Hawton, Annie / Law, Graham / Rowan, Elise / das Nair, Roshan

    NIHR open research

    2022  Volume 2, Page(s) 39

    Abstract: Background: Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the central nervous system (CNS), increasing in incidence and prevalence across both developed and developing countries. Cognitive difficulties are common ... ...

    Abstract Background: Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the central nervous system (CNS), increasing in incidence and prevalence across both developed and developing countries. Cognitive difficulties are common in MS sufferers with 70% experiencing difficulties in higher-level brain functioning such as planning, attention, problem solving, and memory. Computerised cognitive training programmes may hold promise as a treatment option for improving cognitive function in people with MS, subject to exploring and addressing potential barriers to usability and acceptability.
    Methods: This study aimed to test the usability and acceptability of a computerised cognitive training intervention-Strengthening Mental Abilities Through Relational Training (SMART) -for people with MS, through a mostly qualitative prefeasibility design (
    Results: Results show SMART to have satisfactory usability with participants reacting positively to the formatting, visuality, and process of the interface. Minor suggestions were made on how best to adapt SMART for people with MS, but the programme and facilitative support were generally perceived to be acceptable, with participants expressing positive feelings about taking part in the intervention, despite associated burdens.
    Conclusions: This prefeasibility study provides preliminary evidence of the usability and acceptability of SMART as a computerised cognitive training programme for people with MS. We conclude that we can now move forward with a feasibility trial of SMART, with the intention of proceeding to a definitive trial with cost-effectiveness analysis.
    Language English
    Publishing date 2022-05-23
    Publishing country England
    Document type Journal Article
    ISSN 2633-4402
    ISSN (online) 2633-4402
    DOI 10.3310/nihropenres.13274.1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Strengthening Mental Abilities with Relational Training (SMART) in multiple sclerosis (MS): study protocol for a feasibility randomised controlled trial.

    Golijani-Moghaddam, Nima / Dawson, David L / Evangelou, Nikos / Turton, James / Hawton, Annie / Law, Graham R / Roche, Bryan / Rowan, Elise / Burge, Rupert / Frost, Alexandra C / das Nair, Roshan

    Pilot and feasibility studies

    2022  Volume 8, Issue 1, Page(s) 195

    Abstract: Background: Multiple sclerosis (MS) is a chronic condition of the central nervous system, affecting around 1 in every 600 people in the UK, with 130 new diagnoses every week. Cognitive difficulties are common amongst people with MS, with up to 70% ... ...

    Abstract Background: Multiple sclerosis (MS) is a chronic condition of the central nervous system, affecting around 1 in every 600 people in the UK, with 130 new diagnoses every week. Cognitive difficulties are common amongst people with MS, with up to 70% experiencing deficits in higher-level brain functions-such as planning and problem-solving, attention, and memory. Cognitive deficits make it difficult for people with MS to complete everyday tasks and limit their abilities to work, socialise, and live independently. There is a clear need-and recognised research priority-for treatments that can improve cognitive functioning in people with MS. The absence of effective cognitive interventions exacerbates burdens on the services accessed by people with MS-requiring these services to manage sequelae of untreated cognitive deficits, including reduced quality of life, greater disability and dependence, and poorer adherence to disease-modifying treatments. Our planned research will fill the evidence gap through developing-and examining the feasibility of trialling-a novel online cognitive rehabilitation programme for people with MS (SMART). The SMART programme directly trains relational skills (the ability to flexibly relate concepts to one another) based on theory that these skills are critical to broader cognitive functioning.
    Methods: The primary objective of this study aims to conduct a feasibility study to inform the development of a definitive trial of SMART for improving cognitive functioning in people with MS. The secondary objective is to develop the framework for a cost-effectiveness analysis alongside a definitive trial, and the exploratory objective is to assess the signal of efficacy.
    Discussion: As a feasibility trial, outcomes are unlikely to immediately effect changes to NHS practice. However, this is a necessary step towards developing a definitive trial-and will give us a signal of efficacy, a prerequisite for progression to a definitive trial. If found to be clinically and cost-effective, the latter trial could create a step-change in MS cognitive rehabilitation-improving service delivery and optimising support with limited additional resources.
    Trial registration: Registration ID: ClnicalTrials.gov: NCT04975685-registered on July 23rd, 2021.
    Protocol version: 2.0, 25 November 2021.
    Language English
    Publishing date 2022-09-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2809935-7
    ISSN 2055-5784
    ISSN 2055-5784
    DOI 10.1186/s40814-022-01152-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The inflammatory basis of exercise-induced bronchoconstriction.

    Brannan, John D / Turton, James A

    The Physician and sportsmedicine

    2010  Volume 38, Issue 4, Page(s) 67–73

    Abstract: Exercise-induced bronchoconstriction (EIB) is common in individuals with asthma, and may be observed even in the absence of a clinical diagnosis of asthma. Exercise-induced bronchoconstriction can be diagnosed via standardized exercise protocols, and ... ...

    Abstract Exercise-induced bronchoconstriction (EIB) is common in individuals with asthma, and may be observed even in the absence of a clinical diagnosis of asthma. Exercise-induced bronchoconstriction can be diagnosed via standardized exercise protocols, and anti-inflammatory therapy with inhaled corticosteroids (ICS) is often warranted. Exercise-related symptoms are commonly reported in primary care; however, access to standardized exercise protocols to assess EIB are often restricted because of the need for specialized equipment, as well as time constraints. Symptoms and lung function remain the most accessible indicators of EIB, yet these are poor predictors of its presence and severity. Evidence suggests that exercise causes the airways to narrow as a result of the osmotic and thermal consequences of respiratory water loss. The increase in airway osmolarity leads to the release of bronchoconstricting mediators (eg, histamine, prostaglandins, leukotrienes) from inflammatory cells (eg, mast cells and eosinophils). The objective assessment of EIB suggests the presence of airway inflammation, which is sensitive to ICS in association with a responsive airway smooth muscle. Surrogate tests for EIB, such as eucapnic voluntary hyperpnea or the osmotic challenge tests, cause airway narrowing via a similar mechanism, and a response indicates likely benefit from ICS therapy. The complete inhibition of EIB with ICS therapy in individuals with asthma may be a useful marker of control of airway pathology. Furthermore, inhibition of EIB provides additional, useful information regarding the identification of clinical control based on symptoms and lung function. This article explores the inflammatory basis of EIB in asthma as well as the effect of ICS on the pathophysiology of EIB.
    MeSH term(s) Adrenal Cortex Hormones/therapeutic use ; Anti-Inflammatory Agents/therapeutic use ; Asthma, Exercise-Induced/drug therapy ; Asthma, Exercise-Induced/physiopathology ; Bronchoconstriction/physiology ; Bronchodilator Agents/therapeutic use ; Humans ; Inflammation/drug therapy ; Inflammation/physiopathology ; Inflammation Mediators/physiology ; Osmolar Concentration ; Respiratory Function Tests ; Water Loss, Insensible
    Chemical Substances Adrenal Cortex Hormones ; Anti-Inflammatory Agents ; Bronchodilator Agents ; Inflammation Mediators
    Language English
    Publishing date 2010-12
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 753046-8
    ISSN 2326-3660 ; 0091-3847
    ISSN (online) 2326-3660
    ISSN 0091-3847
    DOI 10.3810/psm.2010.12.1827
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial.

    Topcu, Gogem / Smith, Laura / Mhizha-Murira, Jacqueline R / Goulden, Nia / Hoare, Zoë / Drummond, Avril / Fitzsimmons, Deborah / Evangelou, Nikos / Schmierer, Klaus / Tallantyre, Emma C / Leighton, Paul / Allen-Philbey, Kimberley / Stennett, Andrea / Bradley, Paul / Bale, Clare / Turton, James / das Nair, Roshan

    Pilot and feasibility studies

    2022  Volume 8, Issue 1, Page(s) 123

    Abstract: Background: Cognitive problems affect up to 70% of people with multiple sclerosis (MS), which can negatively impact mood, ability to work, and quality of life. Addressing cognitive problems is a top 10 research priority for people with MS. Our ongoing ... ...

    Abstract Background: Cognitive problems affect up to 70% of people with multiple sclerosis (MS), which can negatively impact mood, ability to work, and quality of life. Addressing cognitive problems is a top 10 research priority for people with MS. Our ongoing research has systematically developed a cognitive screening and management pathway (NEuRoMS) tailored for people with MS, involving a brief cognitive evaluation and rehabilitation intervention. The present study aims to assess the feasibility of delivering the pathway and will inform the design of a definitive randomised controlled trial (RCT) to investigate the clinical and cost-effectiveness of the intervention and eventually guide its clinical implementation.
    Methods: The feasibility study is in three parts. Part 1 involves an observational study of those who receive screening and support for cognitive problems, using routinely collected clinical data. Part 2 is a two-arm, parallel group, multicentre, feasibility RCT with a nested fidelity evaluation. This part will evaluate the feasibility of undertaking a definitive trial comparing the NEuRoMS intervention plus usual care to usual care only, amongst people with MS with mild cognitive problems (n = 60). In part 3, semi-structured interviews will be undertaken with participants from part 2 (n = 25), clinicians (n = 9), and intervention providers (n = 3) involved in delivering the NEuRoMS cognitive screening and management pathway. MS participants will be recruited from outpatient clinics at three UK National Health Service hospitals.
    Discussion: Timely screening and effective management of cognitive problems in MS are urgently needed due to the detrimental consequences of cognitive problems on people with MS, the healthcare system, and wider society. The NEuRoMS intervention is based on previous and extant literature and has been co-constructed with relevant stakeholders. If effective, the NEuRoMS pathway will facilitate timely identification and management of cognitive problems in people with MS.
    Trial registration: ISRCTN11203922 . Prospectively registered on 09.02.2021.
    Language English
    Publishing date 2022-06-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 2809935-7
    ISSN 2055-5784
    ISSN 2055-5784
    DOI 10.1186/s40814-022-01073-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A ward-based time study of paper and electronic documentation for recording vital sign observations.

    Wong, David / Bonnici, Timothy / Knight, Julia / Gerry, Stephen / Turton, James / Watkinson, Peter

    Journal of the American Medical Informatics Association : JAMIA

    2017  Volume 24, Issue 4, Page(s) 717–721

    Abstract: Objective: To investigate time differences in recording observations and an early warning score using traditional paper charts and a novel e-Obs system in clinical practice.: Methods: Researchers observed the process of recording observations and ... ...

    Abstract Objective: To investigate time differences in recording observations and an early warning score using traditional paper charts and a novel e-Obs system in clinical practice.
    Methods: Researchers observed the process of recording observations and early warning scores across 3 wards in 2 university teaching hospitals immediately before and after introduction of the e-Obs system. The process of recording observations included both measurement and documentation of vital signs. Interruptions were timed and subtracted from the measured process duration. Multilevel modeling was used to compensate for potential confounding factors.
    Results: In all, 577 nurse events were observed (281 paper, 296 e-Obs). The geometric mean time to take a complete set of vital signs was 215 s (95% confidence interval [CI], 177 s-262 s) on paper, and 150 s (95% CI, 130 s-172 s) electronically. The treatment effect ratio was 0.70 (95% CI, 0.57-0.85, P  < .001). The treatment effect ratio in ward 1 was 0.37 (95% CI, 0.26-0.53), in ward 2 was 0.98 (95% CI, 0.70-1.38), and in ward 3 was 0.93 (95% CI, 0.66-1.33).
    Discussion: Introduction of an e-Obs system was associated with a statistically significant reduction in overall time to measure and document vital signs electronically compared to paper documentation. The reductions in time varied among wards and were of clinical significance on only 1 of 3 wards studied.
    Conclusion: Our results suggest that introduction of an e-Obs system could lower nursing workload as well as increase documentation quality.
    MeSH term(s) Documentation/methods ; Efficiency ; Electronic Health Records ; Hospitals, University ; Humans ; Nursing Records ; Patients' Rooms/organization & administration ; Time Factors ; Time and Motion Studies ; Vital Signs
    Language English
    Publishing date 2017-03-23
    Publishing country England
    Document type Comparative Study ; Journal Article ; Observational Study
    ZDB-ID 1205156-1
    ISSN 1527-974X ; 1067-5027
    ISSN (online) 1527-974X
    ISSN 1067-5027
    DOI 10.1093/jamia/ocw186
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Genomic epidemiology of clinical Campylobacter spp. at a single health trust site.

    Dunn, Steven J / Pascoe, Ben / Turton, James / Fleming, Vicki / Diggle, Mathew / Sheppard, Samuel K / McNally, Alan / Manning, Georgina

    Microbial genomics

    2018  Volume 4, Issue 10

    Abstract: Campylobacter is the leading cause of bacterial enteritis in the developed world, and infections with the organism are largely sporadic in nature. Links between sporadic cases have not been established, with the majority of infections thought to be ... ...

    Abstract Campylobacter is the leading cause of bacterial enteritis in the developed world, and infections with the organism are largely sporadic in nature. Links between sporadic cases have not been established, with the majority of infections thought to be caused by genetically distinct isolates. Using a read-mapping approach, 158 clinical isolates collected during 2014 from the greater Nottinghamshire area were analysed to assess the local population structure and investigate potential case linkages between sporadic cases of campylobacteriosis. Four instances (2.5 %) of case linkage were observed across the dataset. This study demonstrates that case linkage does occur between sporadic Campylobacter infections, and provides evidence that a dual multi-locus sequence typing/within-lineage single nucleotide polymorphism typing approach to Campylobacter genomic epidemiology provides a benefit to public-health investigations.
    MeSH term(s) Bacterial Typing Techniques ; Campylobacter/classification ; Campylobacter/genetics ; Campylobacter/isolation & purification ; Campylobacter Infections/epidemiology ; Campylobacter Infections/genetics ; Campylobacter Infections/microbiology ; Enteritis/epidemiology ; Enteritis/genetics ; Enteritis/microbiology ; Humans ; Molecular Epidemiology ; Multilocus Sequence Typing
    Language English
    Publishing date 2018-10-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2835258-0
    ISSN 2057-5858 ; 2057-5858
    ISSN (online) 2057-5858
    ISSN 2057-5858
    DOI 10.1099/mgen.0.000227
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Feasibility and acceptability of using bronchial hyperresponsiveness to manage asthma in primary care: a pilot study.

    Turton, James A / Glasgow, Nicholas J / Brannan, John D

    Primary care respiratory journal : journal of the General Practice Airways Group

    2011  Volume 21, Issue 1, Page(s) 28–34

    Abstract: Aims: To determine if indirect testing for bronchial hyperresponsiveness (BHR) to monitor inhaled corticosteroid (ICS) treatment in asthma is feasible and acceptable in primary care.: Methods: Fourteen adult patients with asthma aged 22-70 years (4M: ...

    Abstract Aims: To determine if indirect testing for bronchial hyperresponsiveness (BHR) to monitor inhaled corticosteroid (ICS) treatment in asthma is feasible and acceptable in primary care.
    Methods: Fourteen adult patients with asthma aged 22-70 years (4M:10F, forced expiratory volume in 1 s >70% predicted) taking ICS performed a test for BHR using mannitol on three visits 6 weeks apart. ICS dose adjustments were made based on the presence of BHR. The Asthma Quality of Life Questionnaire (AQLQ) and the Asthma Control Questionnaire were used at each visit. A semi structured interview at study exit assessed subject acceptability.
    Results: BHR did not return in those with no BHR at study entry (n=9) with decreasing ICS dose. Improvements in BHR with increasing ICS dose (n=5) were observed with clinically significant improvements in AQLQ (mean score increase >0.5, p=0.02). Feasibility and acceptability of BHR testing was demonstrated.
    Conclusions: It is feasible and acceptable to perform BHR testing using mannitol to help identify patients with asthma who would benefit from ICS dose increases and those with no BHR who could have a dose reduction.
    Trial registration: Australia New Zealand Clinical Trial Registry ACTRN12610000807055.
    MeSH term(s) Administration, Inhalation ; Adult ; Aged ; Anti-Inflammatory Agents/therapeutic use ; Asthma/classification ; Asthma/drug therapy ; Bronchial Hyperreactivity/drug therapy ; Bronchial Provocation Tests/methods ; Bronchoconstrictor Agents ; Feasibility Studies ; Female ; Forced Expiratory Volume/drug effects ; Humans ; Male ; Mannitol ; Middle Aged ; Pilot Projects ; Primary Health Care/methods ; Treatment Outcome
    Chemical Substances Anti-Inflammatory Agents ; Bronchoconstrictor Agents ; Mannitol (3OWL53L36A)
    Language English
    Publishing date 2011-09-21
    Publishing country England
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2129033-7
    ISSN 1475-1534 ; 1475-1534
    ISSN (online) 1475-1534
    ISSN 1475-1534
    DOI 10.4104/pcrj.2011.00079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Correction: Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.

    Chaudhury, Sultan / Brookes, Keeley J / Patel, Tulsi / Fallows, Abigail / Guetta-Baranes, Tamar / Turton, James C / Guerreiro, Rita / Bras, Jose / Hardy, John / Francis, Paul T / Croucher, Rebecca / Holmes, Clive / Morgan, Kevin

    Translational psychiatry

    2019  Volume 9, Issue 1, Page(s) 167

    Abstract: An amendment to this paper has been published and can be accessed via a link at the top of the paper. ...

    Abstract An amendment to this paper has been published and can be accessed via a link at the top of the paper.
    Language English
    Publishing date 2019-06-11
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2609311-X
    ISSN 2158-3188 ; 2158-3188
    ISSN (online) 2158-3188
    ISSN 2158-3188
    DOI 10.1038/s41398-019-0503-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Examining diabetic heel ulcers through an ecological lens: microbial community dynamics associated with healing and infection.

    Sloan, Tim J / Turton, James C / Tyson, Jess / Musgrove, Alison / Fleming, Vicki M / Lister, Michelle M / Loose, Matthew W / Sockett, R Elizabeth / Diggle, Mathew / Game, Frances L / Jeffcoate, William

    Journal of medical microbiology

    2019  Volume 68, Issue 2, Page(s) 230–240

    Abstract: Purpose: While some micro-organisms, such as Staphylococcus aureus, are clearly implicated in causing tissue damage in diabetic foot ulcers (DFUs), our knowledge of the contribution of the entire microbiome to clinical outcomes is limited. We profiled ... ...

    Abstract Purpose: While some micro-organisms, such as Staphylococcus aureus, are clearly implicated in causing tissue damage in diabetic foot ulcers (DFUs), our knowledge of the contribution of the entire microbiome to clinical outcomes is limited. We profiled the microbiome of a longitudinal sample series of 28 people with diabetes and DFUs of the heel in an attempt to better characterize the relationship between healing, infection and the microbiome.
    Methodology: In total, 237 samples were analysed from 28 DFUs, collected at fortnightly intervals for 6 months or until healing. Microbiome profiles were generated by 16S rRNA gene sequence analysis, supplemented by targeted nanopore sequencing.Result/Key findings. DFUs which failed to heal during the study period (20/28, 71.4 %) were more likely to be persistently colonized with a heterogeneous community of micro-organisms including anaerobes and Enterobacteriaceae (log-likelihood ratio 9.56, P=0.008). During clinically apparent infection, a reduction in the diversity of micro-organisms in a DFU was often observed due to expansion of one or two taxa, with recovery in diversity at resolution. Modelling of the predicted species interactions in a single DFU with high diversity indicated that networks of metabolic interactions may exist that contribute to the formation of stable communities.
    Conclusion: Longitudinal profiling is an essential tool for improving our understanding of the microbiology of chronic wounds, as community dynamics associated with clinical events can only be identified by examining changes over multiple time points. The development of complex communities, particularly involving Enterobacteriaceae and strict anaerobes, may be contributing to poor outcomes in DFUs and requires further investigation.
    MeSH term(s) Aged ; Analysis of Variance ; Anti-Bacterial Agents/therapeutic use ; Casts, Surgical ; Cluster Analysis ; Diabetic Foot/drug therapy ; Diabetic Foot/microbiology ; Diabetic Foot/physiopathology ; Diabetic Foot/therapy ; Female ; Humans ; Infections/complications ; Infections/drug therapy ; Infections/microbiology ; Male ; Markov Chains ; Microbiota/genetics ; Middle Aged ; RNA, Ribosomal, 16S/genetics ; Sequence Analysis, DNA ; Wound Healing
    Chemical Substances Anti-Bacterial Agents ; RNA, Ribosomal, 16S
    Language English
    Publishing date 2019-01-09
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 218356-0
    ISSN 1473-5644 ; 0022-2615
    ISSN (online) 1473-5644
    ISSN 0022-2615
    DOI 10.1099/jmm.0.000907
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top